UTEP researchers develop nanohybrid vehicle to optimally deliver drugs into the human body

The researchers discovered that encapsulating ellagic acid in chitosan, a sugar, reduces its inherent cytotoxicity while enhancing its antioxidant properties. The chitosan shell, which makes up the hard outer skeleton of shellfish, also permits EA delivery via a rapid burst phase and a relatively slow phase. This further enhances the drug delivery because the nanohybrid vehicle is uniquely suited for drug release over extended time periods.